Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Huiqing Xu
Automated Manufacturing of CD20.19 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cells at an Academic Center for a Phase I Clinical Trial in Relapsed, Refractory NHL
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Probabilistic en Route Sector Traffic Demand Prediction Based Upon Statistical Analysis of Error Distribution Characteristics
Journal of Advanced Transportation
Management
Mechanical Engineering
Automotive Engineering
Economics
Strategy
Computer Science Applications
Econometrics
Related publications
Chimeric Antigen Receptor T-Cells (Car-T) for Refractory and Relapsed Burkitt's Lymphoma: Early Response in Pediatric Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Third-Generation Anti-Cd19 Chimeric Antigen Receptor T-Cells Incorporating a TLR2 Domain for Relapsed or Refractory B-Cell Lymphoma: A Phase I Clinical Trial Protocol (ENABLE)
BMJ Open
Medicine
Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin's Lymphoma: An Open-Label Phase 1 Trial
The Lancet
Medicine
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
768. Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Development of a Novel Anti-Cd19 Chimeric Antigen Receptor for a Spanish Approved Clinical Trial: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology
Cd30-Chimeric Antigen Receptor (Car) T Cells for Therapy of Hodgkin Lymphoma (Hl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T Cells Alone or in Combination With Ibrutinib for Relapsed and/or Refractory CLL
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
